132 related articles for article (PubMed ID: 28977697)
1. Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides.
Mascolo M; Romano MF; Ilardi G; Romano S; Baldo A; Scalvenzi M; Argenziano G; Merolla F; Russo D; Varricchio S; Pagliuca F; Russo M; Ciancia G; De Rosa G; Staibano S
J Eur Acad Dermatol Venereol; 2018 May; 32(5):735-744. PubMed ID: 28977697
[TBL] [Abstract][Full Text] [Related]
2. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
3. FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma.
Romano S; Xiao Y; Nakaya M; D'Angelillo A; Chang M; Jin J; Hausch F; Masullo M; Feng X; Romano MF; Sun SC
Nucleic Acids Res; 2015 Aug; 43(14):6983-93. PubMed ID: 26101251
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD31 in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Olbromski M; Podhorska-Okolow M; Szepietowski JC; Dziegiel P
Anticancer Res; 2016 Sep; 36(9):4575-82. PubMed ID: 27630298
[TBL] [Abstract][Full Text] [Related]
5. TRAF2 and FKBP51 as possible markers for identification of suitable melanoma tumors for tumor necrosis factor-α inhibition.
Romano S; D'Arrigo P; Tufano M; Staibano S; Rea A; Merolla F; Ilardi G; Petrella A; Romano MF
Melanoma Res; 2019 Apr; 29(2):145-150. PubMed ID: 30451787
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis.
Gu X; Wang Y; Zhang G; Li W; Tu P
J Dermatol; 2013 Aug; 40(8):596-605. PubMed ID: 23682716
[TBL] [Abstract][Full Text] [Related]
7. FKBP51 protects 661w cell culture from staurosporine-induced apoptosis.
Daudt DR; Yorio T
Mol Vis; 2011; 17():1172-81. PubMed ID: 21617754
[TBL] [Abstract][Full Text] [Related]
8. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
[TBL] [Abstract][Full Text] [Related]
9. Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides.
Daggett RN; Kurata M; Abe S; Onishi I; Miura K; Sawada Y; Tanizawa T; Kitagawa M
Br J Dermatol; 2014 Oct; 171(4):722-31. PubMed ID: 24725174
[TBL] [Abstract][Full Text] [Related]
10. Decreased progranulin expression in Mycosis fungoides: a possible association with the high frequency of skin infections.
Nakajima R; Miyagaki T; Kamijo H; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
Eur J Dermatol; 2018 Dec; 28(6):790-794. PubMed ID: 30530405
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
12. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
13. SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides.
Chen B; Zheng Y; Zhu J; Liang Y
Exp Dermatol; 2019 Nov; 28(11):1279-1288. PubMed ID: 31461795
[TBL] [Abstract][Full Text] [Related]
14. Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells.
Romano S; D'Angelillo A; Pacelli R; Staibano S; De Luna E; Bisogni R; Eskelinen EL; Mascolo M; Calì G; Arra C; Romano MF
Cell Death Differ; 2010 Jan; 17(1):145-57. PubMed ID: 19696786
[TBL] [Abstract][Full Text] [Related]
15. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
16. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
[TBL] [Abstract][Full Text] [Related]
17. Silencing of FKBP51 alleviates the mechanical pain threshold, inhibits DRG inflammatory factors and pain mediators through the NF-kappaB signaling pathway.
Yu HM; Wang Q; Sun WB
Gene; 2017 Sep; 627():169-175. PubMed ID: 28629826
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids modulate NF-kappaB-dependent gene expression by up-regulating FKBP51 expression in Newcastle disease virus-infected chickens.
Park J; Kim M; Na G; Jeon I; Kwon YK; Kim JH; Youn H; Koo Y
Mol Cell Endocrinol; 2007 Nov; 278(1-2):7-17. PubMed ID: 17870233
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of FKBP51 in human cancers.
Staibano S; Mascolo M; Ilardi G; Siano M; De Rosa G
Curr Opin Pharmacol; 2011 Aug; 11(4):338-47. PubMed ID: 21530399
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
